EXOSC5 Polyklonaler Antikörper

EXOSC5 Polyklonal Antikörper für IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Ratte

Anwendung

WB, IP, IHC, ELISA

Konjugation

Unkonjugiert

Publikationen

3

Rezensionen (2)

Kat-Nr. : 15627-1-AP

Synonyme

CML28, EXOSC5, exosome component 5, hRrp46p, p12B, RRP41B, RRP46, Rrp46p

---

Galerie der Validierungsdaten

• 

  WB analysis using 15627-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 15627-1-AP (EXOSC5 antibody) at dilution of 1:1500 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 15627-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 15627-1-AP (EXOSC5 antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

• 

  WB analysis of Raji using 15627-1-AP

  Raji cells were subjected to SDS PAGE followed by western blot with 15627-1-AP (EXOSC5 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HeLa using 15627-1-AP

  IP result of anti-EXOSC5 (IP:15627-1-AP, 4ug; Detection:15627-1-AP 1:300) with HeLa cells lysate 2800 ug.

• 

  IHC staining of human breast cancer using 15627-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 15627-1-AP (EXOSC5 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human breast cancer using 15627-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 15627-1-AP (EXOSC5 antibody) at dilution of 1:50 (under 40x lens).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: HEK-293-Zellen, HeLa-Zellen, K-562-Zellen, Raji-Zellen
• Erfolgreiche IP: HeLa-Zellen
• Erfolgreiche Detektion in IHC: humanes Mammakarzinomgewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:3000
• Immunpräzipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunhistochemie (IHC): IHC : 1:20-1:200

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• WB: See 2 publications below
• IHC: See 2 publications below

Produktinformation

15627-1-AP bindet in WB, IP, IHC, ELISA EXOSC5 und zeigt Reaktivität mit human, Ratten

• Getestete Reaktivität: human, Ratte
• In Publikationen genannte Reaktivität: human
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: EXOSC5 fusion protein Ag8098
• Vollständiger Name: exosome component 5
• Berechnetes Molekulargewicht: 235 aa, 25 kDa
• Beobachtetes Molekulargewicht: 28-30 kDa
• GenBank-Zugangsnummer: BC007742
• Gene symbol: EXOSC5
• Gene ID (NCBI): 56915
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CML28 is a component of the human exosome, which is a multiprotein complex involved in the 3′ processing and degradation of RNA [PMID:12359762]. CML28 is a novel 28 kDa TAA identified by serological analysis of cDNA expression libraries (SEREX) screening of a chronic myeloid leukemia (CML) cDNA expression library. As a potential target for tumor-specific immunotherapy, CML28 is superior to other known TAAs characterized by its broader spectrum expression in tumor cells and stricter expression in normal tissues [PMID:16815301].

Publikationen

Species	Application	Title
human	WB,IHC	J Cancer; EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways.; Authors - Xiangliu Chen
human	IHC	Int J Mol Sci; Integrated Bioinformatic Investigation of EXOSCs in Hepatocellular Carcinoma Followed by the Preliminary Validation of EXOSC5 in Cell Proliferation; Authors - Yujing Zhang
human	WB	Life Sci Alliance; Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication; Authors - Tobias Moll

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.

---

FH

Tsimafei (Verified Customer) (07-06-2022)

Reduction of Exosc5 is observed when comparing depletion vs control. Antibodies were incubated ON at 4C.

• Applications: Western Blot
• Primary Antibody Dilution: 1:5000
• Cell Tissue Type: mESCs

EXOSC5 Antibody Western Blot validation (1:5000 dilution) in mESCs (Cat no:15627-1-AP)

FH

Nikolaus (Verified Customer) (05-24-2022)

Depletion is a conditional KO time-course; strong cross-reactivity with Bio-Rad dual stain ladder (25 kDa band)

• Applications: Western Blot
• Primary Antibody Dilution: 1/2000
• Cell Tissue Type: mESC

EXOSC5 Antibody Western Blot validation (1/2000 dilution) in mESC (Cat no:15627-1-AP)